HRTX

Heron Therapeutics, Inc. - Common Stock (HRTX)

About Heron Therapeutics, Inc. - Common Stock (HRTX)

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in Cary, NC.

Details

Daily high

$0.30

Daily low

$0.27

Price at open

$0.28

52 Week High

$1.58

52 Week Low

$0.26

Market cap

51.3M

Dividend yield

Volume

1.2M

Avg. volume

2.1M

P/E ratio

-1.42

Heron Therapeutics, Inc. - Common Stock News